Charity Scripture - 01 Dec 2021 Form 3 Insider Report for BELLICUM PHARMACEUTICALS, INC

Signature
Charity Scripture
Issuer symbol
N/A
Transactions as of
01 Dec 2021
Net transactions value
$0
Form type
3
Filing time
02 Dec 2021, 14:21:48 UTC
Next filing
16 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BLCM Common Stock 14,587 01 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BLCM Stock Option (right to buy) 01 Dec 2021 Common Stock 2,500 $4.41 Direct F1
holding BLCM Stock Option (right to buy) 01 Dec 2021 Common Stock 19,300 $1.36 Direct F2
holding BLCM Stock Option (right to buy) 01 Dec 2021 Common Stock 20,000 $7.13 Direct F3
holding BLCM Stock Option (right to buy) 01 Dec 2021 Common Stock 35,000 $2.97 Direct F4
holding BLCM Stock Option (right to buy) 01 Dec 2021 Common Stock 50,000 $2.88 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option vest and became exercisable on October 1, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
F2 25% of the shares subject to the stock option vest and became exercisable on February 3, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
F3 100% of the shares subject to the stock option vest and became exercisable on August 3, 2021.
F4 50% of the shares subject to the stock option vest and become exercisable on December 15, 2021, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter.
F5 50% of the shares subject to the stock option vest and become exercisable on August 16, 2022, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter.